Articles |
From the Cardiovascular Division, Department of Medicine, and Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, and the Respiratory Physiology Program, Harvard School of Public Health (L.K.), Boston, Mass; the Department of Medicine, Johns Hopkins University, Baltimore, Md (C.J.L.); and the Department of Pathology, University of Michigan Medical School, Ann Arbor (S.L.K.).
Correspondence to Ralph A. Kelly, MD, Cardiovascular Division, Brigham and Women's Hospital, 75 Francis St, Boston, MA 02115.
Abstract Unlike large-vessel endothelial
cells in cell culture, cardiac microvascular
endothelial cells (CMEC) isolated from adult rat
ventricular muscle exhibit little detectable constitutive
nitric oxide (NO) synthase activity after isolation in vitro but
respond to specific combinations of inflammatory mediators with an
increase in inducible NO synthase (iNOS; type 2 NO synthase) activity.
CMEC iNOS is induced by soluble inflammatory mediators in
lipopolysaccharide-activated rat alveolar
macrophageconditioned medium at 24 hours, and this induction
can be partially prevented by either interleukin-1 (IL-1) receptor
antagonist or a polyclonal antirat tumor necrosis
factor-
(TNF-
) antiserum. Interferon-
(IFN-
), which by
itself does not induce iNOS in CMEC, potentiates and accelerates iNOS
induction by IL-1ß. Transforming growth factor-ß (TGF-ß)
decreases iNOS activity, protein content, and mRNA abundance in
IL-1ß and IFN-
pretreated CMEC. To determine whether NO
released by CMEC would affect myocyte contractile function in vitro,
freshly isolated ARVM were allowed to settle onto confluent,
serum-starved CMEC that had been pretreated for 24 hours with IL-1ß,
a cytokine that alone does not affect myocyte contractile
function in vitro. Baseline contractile amplitude, at 2 Hz and 37°C,
of myocytes in heterotypic culture with IL-1ßpretreated CMEC was
not different from that of myocytes in control, homotypic myocyte
cultures. However, cocultured myocytes exhibited decreased contractile
responsiveness to 2 nmol/L isoproterenol compared with control cells,
and this could be reversed by the addition of 1 mmol/L
NG-monomethyl-L-arginine,
an inhibitor of NOS. Thus, activation of
endothelial cell iNOS by specific cytokines
affects the contractile responsiveness to isoproterenol of adjacent
cardiac myocytes in vitro. Reciprocal cell-cell signaling leading to
TGF-ß release and activation could act to limit the extent of
endothelial cell iNOS induction in vivo.
Key Words: interleukin-1 interferon-
transforming growth factor-ß interleukin-1 receptor antagonist
This article has been cited by other articles:
![]() |
A. Kumar, B. Paladugu, J. Mensing, A. Kumar, and J. E. Parrillo Nitric oxide-dependent and -independent mechanisms are involved in TNF-{alpha}-induced depression of cardiac myocyte contractility Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2007; 292(5): R1900 - R1906. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Zimmermann, M. Kochs, T. P. Zwaka, M. Bienek-Ziolkowski, M. Hoher, V. Hombach, and J. Torzewski Prognostic role of myocardial tumor necrosis factor-alpha and terminal complement complex expression in patients with dilated cardiomyopathy Eur J Heart Fail, January 1, 2007; 9(1): 51 - 54. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. C. Mehra, V. S. Ramgolam, and J. R. Bender Cytokines and cardiovascular disease J. Leukoc. Biol., October 1, 2005; 78(4): 805 - 818. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Peng, R.-E. E. Abdulnour, S. Sammani, S.-F. Ma, E. J. Han, E. J. Hasan, R. Tuder, J. G. N. Garcia, and P. M. Hassoun Inducible Nitric Oxide Synthase Contributes to Ventilator-induced Lung Injury Am. J. Respir. Crit. Care Med., August 15, 2005; 172(4): 470 - 479. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Prabhu Cytokine-Induced Modulation of Cardiac Function Circ. Res., December 10, 2004; 95(12): 1140 - 1153. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-L. Wong, F. O'Kirwan, N. Khan, J. Hannestad, K. H. Wu, D. Elashoff, G. Lawson, P. W. Gold, S. M. McCann, and J. Licinio Identification, characterization, and gene expression profiling of endotoxin-induced myocarditis PNAS, November 25, 2003; 100(24): 14241 - 14246. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. S. Chung, M. Packer, K. H. Lo, A. A. Fasanmade, and J. T. Willerson Randomized, Double-Blind, Placebo-Controlled, Pilot Trial of Infliximab, a Chimeric Monoclonal Antibody to Tumor Necrosis Factor-{alpha}, in Patients With Moderate-to-Severe Heart Failure: Results of the Anti-TNF Therapy Against Congestive Heart failure (ATTACH) Trial Circulation, July 1, 2003; 107(25): 3133 - 3140. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Seguin-Devaux, Y. Devaux, V. Latger-Cannard, S. Grosjean, C. Rochette-Egly, F. Zannad, C. Meistelman, P.-M. Mertes, and D. Longrois Enhancement of the inducible NO synthase activation by retinoic acid is mimicked by RARalpha agonist in vivo Am J Physiol Endocrinol Metab, September 1, 2002; 283(3): E525 - E535. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. EBIHARA, S. N. A. HUSSAIN, G. DANIALOU, W.-K. CHO, S. B. GOTTFRIED, and B. J. PETROF Mechanical Ventilation Protects against Diaphragm Injury in Sepsis . Interaction of Oxidative and Mechanical Stresses Am. J. Respir. Crit. Care Med., January 15, 2002; 165(2): 221 - 228. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Sarkar, P. Vallance, and S. E. Harding Nitric oxide: not just a negative inotrope Eur J Heart Fail, October 1, 2001; 3(5): 527 - 534. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Ferdinandy, H. Danial, I. Ambrus, R. A. Rothery, and R. Schulz Peroxynitrite Is a Major Contributor to Cytokine-Induced Myocardial Contractile Failure Circ. Res., August 4, 2000; 87(3): 241 - 247. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Kinnunen, I. Szokodi, M. G. Nicholls, and H. Ruskoaho Impact of NO on ET-1- and AM-induced inotropic responses: potentiation by combined administration Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2000; 279(2): R569 - R575. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M Shah Inducible nitric oxide synthase and cardiovascular disease Cardiovasc Res, January 1, 2000; 45(1): 148 - 155. [Full Text] [PDF] |
||||
![]() |
J.-L. Balligand Regulation of cardiac {beta}-adrenergic response by nitric oxide Cardiovasc Res, August 15, 1999; 43(3): 607 - 620. [Full Text] [PDF] |
||||
![]() |
A. Iwasaki, A. Matsumori, T. Yamada, T. Shioi, W. Wang, K. Ono, R. Nishio, M. Okada, and S. Sasayama Pimobendan inhibits the production of proinflammatory cytokines and gene expression of inducible nitric oxide synthase in a murine model of viral myocarditis J. Am. Coll. Cardiol., April 1, 1999; 33(5): 1400 - 1407. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Kawai From Myocarditis to Cardiomyopathy: Mechanisms of Inflammation and Cell Death : Learning From the Past for the Future Circulation, March 2, 1999; 99(8): 1091 - 1100. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kumar, R. Brar, P. Wang, L. Dee, G. Skorupa, F. Khadour, R. Schulz, and J. E. Parrillo Role of nitric oxide and cGMP in human septic serum-induced depression of cardiac myocyte contractility Am J Physiol Regulatory Integrative Comp Physiol, January 1, 1999; 276(1): R265 - R276. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Harding, C. H. Davies, A. M. Money-Kyrle, and P. A. Poole-Wilson An inhibitor of nitric oxide synthase does not increase contraction or {beta}-adrenoceptor sensitivity of ventricular myocytes from failing human heart Cardiovasc Res, December 1, 1998; 40(3): 523 - 529. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Bartunek, S. Dempsey, E. O. Weinberg, N. Ito, M. Tajima, S. Rohrbach, and B. H. Lorell Chronic L-arginine treatment increases cardiac cyclic guanosine 5'-monophosphate in rats with aortic stenosis: effects on left ventricular mass and beta-adrenergic contractile reserve J. Am. Coll. Cardiol., August 1, 1998; 32(2): 528 - 535. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Okada, J. Woodcock-Mitchell, J. Mitchell, T. Sakamoto, K. Marutsuka, B. E. Sobel, and S. Fujii Induction of Plasminogen Activator Inhibitor Type 1 and Type 1 Collagen Expression in Rat Cardiac Microvascular Endothelial Cells by Interleukin-1 and Its Dependence on Oxygen-Centered Free Radicals Circulation, June 2, 1998; 97(21): 2175 - 2182. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-L. Balligand and P. J. Cannon Nitric Oxide Synthases and Cardiac Muscle : Autocrine and Paracrine Influences Arterioscler. Thromb. Vasc. Biol., October 1, 1997; 17(10): 1846 - 1858. [Abstract] [Full Text] |
||||
![]() |
H. Ikenouchi, K. Kangawa, H. Matsuo, and Y. Hirata Negative Inotropic Effect of Adrenomedullin in Isolated Adult Rabbit Cardiac Ventricular Myocytes Circulation, May 6, 1997; 95(9): 2318 - 2324. [Abstract] [Full Text] |
||||
![]() |
W. W. Simmons, D. Ungureanu-Longrois, G. K. Smith, T. W. Smith, and R. A. Kelly Glucocorticoids Regulate Inducible Nitric Oxide Synthase by Inhibiting Tetrahydrobiopterin Synthesis and L-Arginine Transport J. Biol. Chem., September 27, 1996; 271(39): 23928 - 23937. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Kelly, J.-L. Balligand, and T. W. Smith Nitric Oxide and Cardiac Function Circ. Res., September 1, 1996; 79(3): 363 - 380. [Full Text] |
||||
![]() |
W. W. Simmons, E. I. Closs, J. M. Cunningham, T. W. Smith, and R. A. Kelly Cytokines and Insulin Induce Cationic Amino Acid Transporter (CAT) Expression in Cardiac Myocytes J. Biol. Chem., May 17, 1996; 271(20): 11694 - 11702. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Singh, J.-L. Balligand, T. A. Fischer, T. W. Smith, and R. A. Kelly Regulation of Cytokine-inducible Nitric Oxide Synthase in Cardiac Myocytes and Microvascular Endothelial Cells J. Biol. Chem., January 12, 1996; 271(2): 1111 - 1117. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Singh, J.-L. Balligand, T. A. Fischer, T. W. Smith, and R. A. Kelly Glucocorticoids Increase Osteopontin Expression in Cardiac Myocytes and Microvascular Endothelial Cells J. Biol. Chem., November 24, 1995; 270(47): 28471 - 28478. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Ungureanu-Longrois, J.-L. Balligand, W. W. Simmons, I. Okada, L. Kobzik, C. J. Lowenstein, S. L. Kunkel, T. Michel, R. A. Kelly, and T. W. Smith Induction of Nitric Oxide Synthase Activity by Cytokines in Ventricular Myocytes Is Necessary but Not Sufficient to Decrease Contractile Responsiveness to ß-Adrenergic Agonists Circ. Res., September 1, 1995; 77(3): 494 - 502. [Abstract] [Full Text] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |